Hyaluronic Acid Dermal Filler Market By Manufacturers, By Type (Single-Phase Product, Duplex Product), By Application (Wrinkle Removal, Lip Augmentation, Rhinoplasty, Others), and By Regions (North America, Europe, Middle East and Africa, Latin America and Asia Pacific) - Global Outlook to 2026
Report ID: 391277 | Feb 2020 | No. of Pages: 120
|
Covid-19 Impact Analysis & Forecast
Global Hyaluronic Acid Dermal Filler Market is valued USD 9.79 Billion in 2019 and is projected is to exhibit 8.9 % CAGR during the forecast period. The market is projected to be around USD 17.78 Billion by 2026. The market is driven by the rising demand for invasive dermal fillers injection to remove wrinkles from the skin and look young.
The hyaluronic acid dermal filler is used to reduce the appearance of fine lines, wrinkles, facial folds, and to create a structural framework and volume to the face and lips. The effects of hyaluronic acid are seen instantly.
Hyaluronic Acid Dermal Filler Market Dynamics
Growth in the global hyaluronic acid dermal filler is driven primarily by rising demand for invasive dermal fillers injection to remove wrinkles from the skin and look young. Increasing demand for youthful and flawless skin via noninvasive and outpatient aesthetic dermatology techniques is expected to drive the market. Furthermore, the rise in medical tourism for aesthetic procedures is anticipated to aid the market.
Additionally, the factors drive the growth of the hyaluronic acid dermal filler market is the increase in technology for injecting the filler into the skin coupled with the increase in consumer's disposable income, which they can now invest in dermal filler procedures. The rising demand for anti-aging products coupled with the growing geriatric population is propelling the global hyaluronic acid-based dermal fillers market growth.
Hyaluronic Acid Dermal Filler Market Insight
Based on the region, North America held the largest market share in 2018 due to the easy availability of products in this region, and its versatile application in cosmetic, and esthetic medicinal procedures, improvements in healthcare facilities due to rapid economic development in countries such as China, Japan, and South Korea have made the Asia Pacific the most profitable market. In these countries, dermal filler treatments are in high demand and are provided in beauty clinics and spas, particularly in urban areas.
Hyaluronic Acid Dermal Filler Market Segmentation
The global Hyaluronic Acid Dermal Filler Market is segmented into type, application, and region. On the basis of the type the market is divided into Single-Phase Product, Duplex Product. Based on application the market is segmented into Wrinkle Removal, Lip Augmentation, Rhinoplasty, Others. And based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Hyaluronic Acid Dermal Filler Market Competitive Landscape
The key players in Hyaluronic Acid Dermal Filler Market are listed as Allergan, Anika Therapeutics Inc., Bioplus Co. Ltd., Bioxis Pharmaceutical, Bohus Biotech AB, Galderma Laboratories L.P, Genzyme Corporation, Laboratories Vivacy, LG Life Sciences, LTD (LG Chem), Merz Pharmaceuticals, Sculpt Luxury Dermal Fillers Ltd, Sinclair Pharma, and Other.
The hyaluronic acid dermal filler is used to reduce the appearance of fine lines, wrinkles, facial folds, and to create a structural framework and volume to the face and lips. The effects of hyaluronic acid are seen instantly.
Hyaluronic Acid Dermal Filler Market Dynamics
Growth in the global hyaluronic acid dermal filler is driven primarily by rising demand for invasive dermal fillers injection to remove wrinkles from the skin and look young. Increasing demand for youthful and flawless skin via noninvasive and outpatient aesthetic dermatology techniques is expected to drive the market. Furthermore, the rise in medical tourism for aesthetic procedures is anticipated to aid the market.
Additionally, the factors drive the growth of the hyaluronic acid dermal filler market is the increase in technology for injecting the filler into the skin coupled with the increase in consumer's disposable income, which they can now invest in dermal filler procedures. The rising demand for anti-aging products coupled with the growing geriatric population is propelling the global hyaluronic acid-based dermal fillers market growth.
Hyaluronic Acid Dermal Filler Market Insight
Based on the region, North America held the largest market share in 2018 due to the easy availability of products in this region, and its versatile application in cosmetic, and esthetic medicinal procedures, improvements in healthcare facilities due to rapid economic development in countries such as China, Japan, and South Korea have made the Asia Pacific the most profitable market. In these countries, dermal filler treatments are in high demand and are provided in beauty clinics and spas, particularly in urban areas.
Hyaluronic Acid Dermal Filler Market Segmentation
The global Hyaluronic Acid Dermal Filler Market is segmented into type, application, and region. On the basis of the type the market is divided into Single-Phase Product, Duplex Product. Based on application the market is segmented into Wrinkle Removal, Lip Augmentation, Rhinoplasty, Others. And based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Hyaluronic Acid Dermal Filler Market Competitive Landscape
The key players in Hyaluronic Acid Dermal Filler Market are listed as Allergan, Anika Therapeutics Inc., Bioplus Co. Ltd., Bioxis Pharmaceutical, Bohus Biotech AB, Galderma Laboratories L.P, Genzyme Corporation, Laboratories Vivacy, LG Life Sciences, LTD (LG Chem), Merz Pharmaceuticals, Sculpt Luxury Dermal Fillers Ltd, Sinclair Pharma, and Other.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. DefinitionChapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & LimitationsChapter 3. Executive SummaryChapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain AnalysisChapter 5. Hyaluronic Acid Dermal Filler Market, By Type
5.1. Hyaluronic Acid Dermal Filler Market, By Type, 2018-2026
5.2. Single-Phase Product
5.3. Duplex ProductChapter 6. Hyaluronic Acid Dermal Filler Market, By Application
6.1. Hyaluronic Acid Dermal Filler Market, by Application, 2018-2026
6.2. Wrinkle Removal
6.3. Lip Augmentation
6.4. Rhinoplasty
6.5. OthersChapter 7. Hyaluronic Acid Dermal Filler Market, By Region
7.1. Hyaluronic Acid Dermal Filler Market, by Region, 2018-2026
7.1.1. North America
7.1.1.1. U.S
7.1.1.2. Rest of North America
7.1.2. Europe
7.1.2.1. U.K.
7.1.2.2. Germany
7.1.2.3. France
7.1.2.4. Rest of the Europe
7.1.3. Middle East & Africa (MEA)
7.1.3.1. GCC
7.1.3.2. North Africa
7.1.3.3. South Africa
7.1.3.4. Rest of MEA
7.1.4. Latin America (LATAM)
7.1.4.1. Brazil
7.1.4.2. Rest of LATAM
7.1.5. Asia Pacific (APAC)
7.1.5.1. India
7.1.5.2. China
7.1.5.3. Japan
7.1.5.4. Rest of the APACChapter 8. Competitive Landscape
8.1.1. Key Strategies Adopted by Players
8.1.2. Market Share/Positioning AnalysisChapter 9. Company Profiles9.1. Allergan
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives9.2. Anika Therapeutics Inc.
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives9.3. Bioplus Co. Ltd.
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives9.4. Bioxis Pharmaceutical
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives9.5 Bohus Biotech AB
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives9.6. Galderma Laboratories L.P
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives9.7. Genzyme Corporation
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives9.8. Laboratories Vivacy
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives9.9. LG Life Sciences
9.9.1. Company Overview
9.9.2. Product Offerings
9.9.3. Financial Performance
9.9.4. Recent Initiatives9.10. LTD (LG Chem)
9.10.1. Company Overview
9.10.2. Product Offerings
9.10.3. Financial Performance
9.10.4. Recent Initiatives9.11. Merz Pharmaceuticals
9.11.1. Company Overview
9.11.2. Product Offerings
9.11.3. Financial Performance
9.11.4. Recent Initiatives9.12. Sculpt Luxury Dermal Fillers Ltd
9.12.1. Company Overview
9.12.2. Product Offerings
9.12.3. Financial Performance
9.12.4. Recent Initiatives 9.13. Sinclair Pharma
9.13.1. Company Overview
9.13.2. Product Offerings
9.13.3. Financial Performance
9.13.4. Recent Initiatives9.14. List of other companies
9.14.1. Company Overview
9.14.2. Product Offerings
9.14.3. Financial Performance
9.14.4. Recent InitiativesChapter 10. Appendix
10.1. About Us
10.2. Glossary of Terms
1.1. Research Objective
1.2. Scope of the Study
1.3. DefinitionChapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & LimitationsChapter 3. Executive SummaryChapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain AnalysisChapter 5. Hyaluronic Acid Dermal Filler Market, By Type
5.1. Hyaluronic Acid Dermal Filler Market, By Type, 2018-2026
5.2. Single-Phase Product
5.3. Duplex ProductChapter 6. Hyaluronic Acid Dermal Filler Market, By Application
6.1. Hyaluronic Acid Dermal Filler Market, by Application, 2018-2026
6.2. Wrinkle Removal
6.3. Lip Augmentation
6.4. Rhinoplasty
6.5. OthersChapter 7. Hyaluronic Acid Dermal Filler Market, By Region
7.1. Hyaluronic Acid Dermal Filler Market, by Region, 2018-2026
7.1.1. North America
7.1.1.1. U.S
7.1.1.2. Rest of North America
7.1.2. Europe
7.1.2.1. U.K.
7.1.2.2. Germany
7.1.2.3. France
7.1.2.4. Rest of the Europe
7.1.3. Middle East & Africa (MEA)
7.1.3.1. GCC
7.1.3.2. North Africa
7.1.3.3. South Africa
7.1.3.4. Rest of MEA
7.1.4. Latin America (LATAM)
7.1.4.1. Brazil
7.1.4.2. Rest of LATAM
7.1.5. Asia Pacific (APAC)
7.1.5.1. India
7.1.5.2. China
7.1.5.3. Japan
7.1.5.4. Rest of the APACChapter 8. Competitive Landscape
8.1.1. Key Strategies Adopted by Players
8.1.2. Market Share/Positioning AnalysisChapter 9. Company Profiles9.1. Allergan
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives9.2. Anika Therapeutics Inc.
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives9.3. Bioplus Co. Ltd.
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives9.4. Bioxis Pharmaceutical
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives9.5 Bohus Biotech AB
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives9.6. Galderma Laboratories L.P
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives9.7. Genzyme Corporation
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives9.8. Laboratories Vivacy
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives9.9. LG Life Sciences
9.9.1. Company Overview
9.9.2. Product Offerings
9.9.3. Financial Performance
9.9.4. Recent Initiatives9.10. LTD (LG Chem)
9.10.1. Company Overview
9.10.2. Product Offerings
9.10.3. Financial Performance
9.10.4. Recent Initiatives9.11. Merz Pharmaceuticals
9.11.1. Company Overview
9.11.2. Product Offerings
9.11.3. Financial Performance
9.11.4. Recent Initiatives9.12. Sculpt Luxury Dermal Fillers Ltd
9.12.1. Company Overview
9.12.2. Product Offerings
9.12.3. Financial Performance
9.12.4. Recent Initiatives 9.13. Sinclair Pharma
9.13.1. Company Overview
9.13.2. Product Offerings
9.13.3. Financial Performance
9.13.4. Recent Initiatives9.14. List of other companies
9.14.1. Company Overview
9.14.2. Product Offerings
9.14.3. Financial Performance
9.14.4. Recent InitiativesChapter 10. Appendix
10.1. About Us
10.2. Glossary of Terms
Cisco
Avaya
Polycom
Alcatel-Lucent
Yealink
Grandstream
NEC
D-Link
Escene
Mitel
Fanvil
Snom
Other
Avaya
Polycom
Alcatel-Lucent
Yealink
Grandstream
NEC
D-Link
Escene
Mitel
Fanvil
Snom
Other
1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market
3. It provides a forward looking perspective on different factors driving or restraining market growth
4. It provides an eight-year forecast assessed on the basis of how the market is expected to grow
5. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segment
6. Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Connect With Us
+1-707-633-0404
sales@search4research.com
Related reports
|
|
(COVID Version) Global Cotton Buds Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 105
|
$3000Buy Now |
|
|
(COVID Version) Global Cotton Balls and Swabs Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 110
|
$3000Buy Now |
|
|
(COVID Version) Global Cosmetic Surgery Equipment Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 108
|
$3000Buy Now |
|
|
(COVID Version) Global Cosmetic Prostheses Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 100
|
$3000Buy Now |
|
|
(COVID Version) Global Cortisone Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use
Publication Month: Oct 2022 | No. of Pages: 103
|
$3000Buy Now |